Regulacje i polityka gospodarcza · 06/10/2008

Bayer Announces Expanded Access to Anthrax Treatment for Emergency Situations

Bayer announced an expanded access program for its anthrax treatment, Cubicin, to provide targeted liability protections for healthcare providers in emergency situations where a credible risk of exposure to Bacillus anthracis exists, in accordance with the Public Readiness and Emergency Preparedness Act.